6558 — SYNergy ScienTech Cashflow Statement
0.000.00%
- TWD2.49bn
- TWD2.11bn
- TWD1.20bn
- 84
- 22
- 55
- 55
Annual cashflow statement for SYNergy ScienTech, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 205 | 78.1 | 5.75 | -86.2 | -45.5 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 6.65 | 11.2 | 18.1 | 19.2 | -0.356 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.89 | -157 | -73.4 | 17.7 | 163 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 244 | 11.5 | 49.3 | 53.7 | 230 |
Capital Expenditures | -374 | -163 | -112 | -72.5 | -56.2 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -9.48 | -20.9 | -0.25 | -4.83 | -1.83 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -383 | -183 | -112 | -77.4 | -58 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 427 | -80.8 | 435 | -417 | -58.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 279 | -258 | 375 | -426 | 122 |